Skip to content

IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study

IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00416611
Acronym
IMPULSION
Enrollment
1000
Registered
2006-12-28
Start date
2006-11-30
Completion date
2007-11-30
Last updated
2009-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Blood Pressure

Keywords

High blood pressure, Awareness, Treatment, Effective Control, Coronary heart disease risk reduction, Hypertension

Brief summary

The objective of this protocol is to improve awareness, treatment, and control of arterial hypertension, within primary prevention of target organ damage, by implementing guidelines, after training of the participating physicians.

Detailed description

Physicians from 20 hospitals and 40 health centres (primary health care settings) were trained to implement guidelines in treating arterial hypertension. There will be a baseline recording of patients with arterial hypertension and then physicians will have to complete a one page form (by ticking pre-specified boxes) about the baseline status of the patients and will have to report the measures they took to improve awareness, treatment, and effective control of arterial hypertension. After a six month effort, physicians will have to complete the same form at study completion. Previous training of physicians and the fact that they will have to report their success in treating hypertension will hopefully contribute to an increase in number of hypertensive patients at blood pressure target, and will minimise the target organ damage. The estimated reduction in coronary heart disease risk will be evaluated by a comparison of this risk (as evaluated by a risk engine, i.e. PROCAM) at study completion with that of baseline.

Interventions

Sponsors

Hellenic Atherosclerosis Society
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Arterial hypertension as defined by the JNC 7 report

Exclusion criteria

* Pregnancy * Lactation * Malignancies with small life expectancy * Unwillingness to participate

Design outcomes

Primary

MeasureTime frame
Efficacy in arterial hypertension control6 months
Efficacy in reducing estimated risk of coronary heart disease6 months

Secondary

MeasureTime frame
Cost effectiveness of arterial hypertension control6 months
Differences between primary and secondary health care settings as well as teaching hospitals6 months

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026